Assenagon Asset Management
AZN icon

Assenagon Asset Management’s AstraZeneca AZN Stock Holding History

Assenagon Asset Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$256M Buy
1,352,177
+422,866
+46% +$79.5M 0.32% 53
2026
Q1 		$183M Buy
929,311
+535,769
+136% +$103M 0.28% 62
2025
Q4 		$72.4M Buy
393,542
+94,365
+32% +$16.6M 0.1% 165
2025
Q3 		$45.9M Sell
299,177
-284,581
-49% -$43.1M 0.06% 230
2025
Q2 		$81.6M Buy
583,758
+196,421
+51% +$27.5M 0.12% 156
2025
Q1 		$56.9M Sell
387,337
-37,357
-9% -$5.4M 0.1% 189
2024
Q4 		$55.7M Sell
424,694
-11,253
-3% -$1.58M 0.09% 189
2024
Q3 		$67.9M Buy
435,947
+169,283
+63% +$27.3M 0.13% 143
2024
Q2 		$41.6M Buy
266,664
+137,512
+106% +$20.7M 0.09% 166
2024
Q1 		$17.5M Buy
+129,152
New +$17.1M 0.04% 307
2023
Q4 		– Sell
-16,547
Closed -$2.24M – 1405
2023
Q3 		$2.24M Buy
+16,547
New +$2.26M 0.01% 818
2023
Q2 		– Sell
-114,719
Closed -$15.9M – 1334
2023
Q1 		$15.9M Sell
114,719
-115,702
-50% -$15.6M 0.06% 286
2022
Q4 		$31.2M Buy
+230,421
New +$28.9M 0.11% 186
2022
Q1 		– Sell
-206,409
Closed -$24M – 1421
2021
Q4 		$24M Sell
206,409
-131,931
-39% -$15.5M 0.07% 190
2021
Q3 		$40.6M Buy
+338,340
New +$39.4M 0.13% 137
2021
Q1 		– Sell
-20,924
Closed -$2.09M – 1198
2020
Q4 		$2.09M Buy
20,924
+11,602
+124% +$1.23M 0.01% 520
2020
Q3 		$1.02M Sell
9,322
-17,536
-65% -$1.95M 0.01% 792
2020
Q2 		$2.84M Sell
26,858
-2,063
-7% -$213K 0.02% 483
2020
Q1 		$2.58M Buy
+28,921
New +$2.72M 0.02% 308

Other funds holding AZN

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
ZIC
ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return
AIM
Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return
CAM
Cidel Asset Management Toronto, Ontario, Ontario, Canada $2.08B AUM 24.89% 1-Year Est. Return
MBI
Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return
SAM
Sycomore Asset Management Paris, France $932M AUM 51.25% 1-Year Est. Return
PAS
Professional Advisory Services Vero Beach, Florida $836M AUM 25.79% 1-Year Est. Return

Assenagon Asset Management's AZN Position: Q2 2026 in Review

Assenagon Asset Management increased its AstraZeneca (AZN) stake by 46% in Q2 2026, buying an estimated $79.5M and bringing the position to 1,352,177 shares worth $256M. The position accounts for 0.32% of the portfolio, ranked #53.

Assenagon Asset Management first reported a position in AZN in Q1 2020 and has held it in 19 quarters since. 351 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Assenagon Asset Management held 1,352,177 shares of AstraZeneca worth $256M as of Q2 2026.
  • Assenagon Asset Management bought 422,866 AstraZeneca shares in Q2 2026, an estimated $79.5M.
  • AstraZeneca made up 0.32% of Assenagon Asset Management's portfolio in Q2 2026, its #53 holding.
  • Assenagon Asset Management first reported a position in AstraZeneca in Q1 2020 and has held it in 19 quarters since.
  • 351 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Assenagon Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.